Heavy Drinking Can Damage Every Part of the Eye
Jun 24, 2022 · Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company Bettie Page Fitness, and author of 2 books – The Little Book of Bettie: Taking a Page from the Queen of Pinups and Bettie Page: The Lost Years.
Ocular Myasthenia Gravis Treatment Options Explained
Jul 20, 2023 · Myasthenia gravis (MG) can occur in 2 forms: a generalized myasthenia gravis (GMG) or purely ocular myasthenia gravis (OMG). Ocular myasthenia gravis is characterized by progressive fatigability of skeletal muscle limited to the orbicularis oculi, levator palpebrae superioris, and the extraocular muscles. 1 Up to half of patients diagnosed with MG present with ocular muscle weakness before ...
Topical 5-Fluorouracil Appropriate for Most Ocular Surface …
Jan 9, 2023 · Most patients with ocular surface squamous neoplasia (OSSN) respond to treatment with topical 5-fluorouracil (5FU) eye drops, with complete resolution achieved in 87% of eyes treated, according to results of a study published in The Ocular Surface.The study shows efficacy in 2 years worth of follow up with minimal side effects.
Photobiomodulation Treatment for Dry AMD Approved By FDA ...
Nov 15, 2024 · A photobiomodulation therapy device has received approval by the US Food and Drug Administration (FDA) to be marketed for the treatment of nonexudative (dry) age-related macular degeneration (AMD), according to statements from the FDA and the manufacturer.The device allows physicians the opportunity to offer a noninvasive treatment for dry AMD with a low-level laser therapy (LLLT) technology. 1,2
Malignant Glaucoma Usually Requires Combined Surgery
Feb 12, 2024 · Malignant glaucoma (MG) treatment requires surgery, and often a combined pars plana antero-central vitrectomy, hyaloido-zonulectomy and iridectomy technique, according to a report published in Ophthalmology Glaucoma.. The study shows the blended procedure resulted in 94.4% success for patients (N=73; median age, 70 [IQR 19.5, range 7 to 92] years; 75.4% women) with malignant glaucoma treated ...
Study: Scleral Lenses Associated With Corneal Edema After …
Scleral lens wearers who previously underwent penetrating keratoplasty (PK) exhibited approximately 3 times more macular edema, and 2.5 times more variability in central corneal response, than those who have healthy eyes in a recent study. 1 While research has indicated corneal complications may be associated with scleral lens wear in patients who undergo PK, this is the first study of the ...
Cataract Therapy Eye Drop May Reverse Progression
Aug 22, 2024 · A cataract therapy eye drop designed to improve visual function in patients with contrast sensitivity (CS) loss due to cataracts is demonstrating that it can also reduce lens density in early phase trials, according to a report published in the American Journal of Ophthalmology.. The cataract therapy drop — referred to as C-KAD — contains an active ingredient, 2.6% ...
Real-World Faricimab Study Shows Efficacy in 3 Doses
Oct 15, 2024 · A real-world faricimab study shows that, for some patients with neovascular age-related macular degeneration (nAMD), 3 loading doses of the anti-vascular endothelial growth factor (anti-VEGF) agent can be administered, instead of the clinical trial-tested 4 loading doses, according to a study published in Clinical Ophthalmology.This approach may yield safe and efficient nAMD drying, fewer ...
Ophthalmology CME/CE Courses - Ophthalmology Advisor
myCME is the premier destination for continuing medical education (CME) and continuing education (CE), committed to providing high-quality, evidence-based, and user-friendly courses tailored to the needs of physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals across 20+ specialties.. Below you’ll find practice-relevant ophthalmology ...
Dry AMD Study Shows Promise With Low-Level Light Therapy ...
Oct 16, 2024 · Photobiomodulation (PBM) using a low-level light therapy device is safe and well-tolerated, and can potentially offer both functional and anatomical improvements in patients with dry non-neovascular, nonexudative age-related macular degeneration (dry AMD), according to study results published in Ophthalmology and Therapy. Researchers conducted a preliminary analysis of the safety, tolerability ...